A. Gonçalves

650 total citations
20 papers, 394 citations indexed

About

A. Gonçalves is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Gonçalves has authored 20 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in A. Gonçalves's work include Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). A. Gonçalves is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). A. Gonçalves collaborates with scholars based in France, United States and Chile. A. Gonçalves's co-authors include Agnès Tallet, D. Azria, Jean‐Philippe Spano, Fabrice Barlési, Philippe Métellus, Alain Carpentier, F. Viret, Olivıer Turrini, Jean‐Robert Delpéro and Gilles Houvenaeghel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

A. Gonçalves

18 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gonçalves France 9 239 197 106 97 86 20 394
Comron Hassanzadeh United States 10 118 0.5× 132 0.7× 36 0.3× 63 0.6× 71 0.8× 22 305
Sujith Baliga United States 12 106 0.4× 173 0.9× 97 0.9× 35 0.4× 114 1.3× 64 404
Eric Yi-Liang Shen Taiwan 9 86 0.4× 253 1.3× 87 0.8× 37 0.4× 100 1.2× 27 441
Thierry Schmitt France 7 68 0.3× 139 0.7× 45 0.4× 60 0.6× 100 1.2× 11 283
Mauro Arcicasa Italy 12 93 0.4× 135 0.7× 109 1.0× 44 0.5× 53 0.6× 28 318
Anupama Chundury United States 11 54 0.2× 160 0.8× 39 0.4× 77 0.8× 89 1.0× 39 356
Caressa Hui United States 10 135 0.6× 88 0.4× 78 0.7× 83 0.9× 84 1.0× 47 344
Amalia Palacios Spain 11 72 0.3× 139 0.7× 48 0.5× 28 0.3× 65 0.8× 29 277
Lucia Giaccherini Italy 12 103 0.4× 117 0.6× 43 0.4× 20 0.2× 98 1.1× 28 257
Mi Hwa Heo South Korea 12 148 0.6× 99 0.5× 18 0.2× 43 0.4× 41 0.5× 28 262

Countries citing papers authored by A. Gonçalves

Since Specialization
Citations

This map shows the geographic impact of A. Gonçalves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gonçalves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gonçalves more than expected).

Fields of papers citing papers by A. Gonçalves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gonçalves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gonçalves. The network helps show where A. Gonçalves may publish in the future.

Co-authorship network of co-authors of A. Gonçalves

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gonçalves. A scholar is included among the top collaborators of A. Gonçalves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gonçalves. A. Gonçalves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gonçalves, A., Susana Ochoa, Steffen Moritz, et al.. (2025). Metacognitive training (MCT) for psychosis: a systematic review and grade recommendations. European Psychiatry. 68(1). e80–e80. 1 indexed citations
2.
Epaillard, Nicolas, Amélie Lusque, William Jacot, et al.. (2024). Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort. ESMO Open. 9(5). 103447–103447. 3 indexed citations
4.
Mailliez, Audrey, Véronique D’Hondt, Amélie Lusque, et al.. (2021). Abstract PD10-08: Outcomes of germline BRCA carriers versus non-carriers in the french national metastatic breast cancer ESME cohort 2008-2016. Cancer Research. 81(4_Supplement). PD10–8. 1 indexed citations
5.
Bay, Jacques‐Olivier, Thierry André, Christophe Caux, et al.. (2019). Retours sur quelques importantes avancées en oncologie et hématologie de 2018 : une sélection du comité de rédaction du Bulletin du Cancer. Bulletin du Cancer. 106(1). 12–23.
7.
Thomas, Fabienne, Isabelle Hennebelle, Caroline Delmas, et al.. (2015). Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio. Clinical Pharmacology & Therapeutics. 99(2). 235–242. 31 indexed citations
8.
Tallet, Agnès, D. Azria, Émilie Le Rhun, et al.. (2014). Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer. International Journal of Molecular Sciences. 15(5). 8138–8152. 4 indexed citations
9.
10.
Tallet, Agnès, D. Azria, Fabrice Barlési, et al.. (2012). Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment. Radiation Oncology. 7(1). 77–77. 163 indexed citations
11.
Turrini, Olivıer, Jacques Ewald, F. Viret, et al.. (2012). Two-stage hepatectomy: Who will not jump over the second hurdle?. European Journal of Surgical Oncology. 38(3). 266–273. 33 indexed citations
12.
Apostolidis, Thémis, et al.. (2008). [Psychosocial approach of the speech of women in metastatic relapse of a breast cancer: the question of temporality].. PubMed. 95(9). 859–69. 6 indexed citations
13.
Carcopino, Xavier, Gilles Houvenaeghel, Max Buttarelli, et al.. (2007). Equivalent survival in patients with advanced stage IB–II and III–IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy. European Journal of Surgical Oncology. 34(5). 569–575. 14 indexed citations
14.
Gonçalves, A., R. Delva, Michel Fabbro, et al.. (2006). Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study. Bone Marrow Transplantation. 37(7). 651–659. 2 indexed citations
15.
Houvenaeghel, Gilles, Max Buttarelli, Xavier Carcopino, et al.. (2006). Place de la chirurgie après chimioradiothérapie des cancers du col localement évolués. Cancer/Radiothérapie. 10(6-7). 471–476. 9 indexed citations
16.
Viret, F., Marc Ychou, Vincent Moutardier, et al.. (2006). Preoperative radiotherapy and docetaxel in resectable pancreatic adenocarcinoma: A phase II trial. Journal of Clinical Oncology. 24(18_suppl). 4099–4099. 2 indexed citations
17.
Gonçalves, A., A.C. Braud, F. Viret, et al.. (2005). High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study.. PubMed. 25(1B). 663–7. 10 indexed citations
18.
Moutardier, Vincent, V. Magnin, Olivıer Turrini, et al.. (2004). Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 60(2). 437–443. 85 indexed citations
19.
Viret, F., Marc Ychou, A. Gonçalves, et al.. (2003). Docetaxel and Radiotherapy and Pancreatic Cancer. Pancreas. 27(3). 214–219. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026